Crinetics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 16:23 ET

Crinetics | 10-K: FY2024 Annual Report

Feb 27 16:13 ET

Crinetics | 8-K: Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 27 16:11 ET

Crinetics | 4: Statement of changes in beneficial ownership of securities-Officer Betz Stephen F.

Feb 24 16:33 ET

Crinetics | 4: Statement of changes in beneficial ownership of securities-Officer Pizzuti Dana

Feb 24 16:33 ET

Crinetics | 4: Statement of changes in beneficial ownership of securities-Officer Knight Jeff E.

Feb 24 16:33 ET

Crinetics | 4: Statement of changes in beneficial ownership of securities-Officer Struthers Richard Scott

Feb 24 16:33 ET

Crinetics | 8-K: Current report

Feb 24 08:52 ET

Crinetics | SCHEDULE 13G/A: Others

Feb 10 13:01 ET

Crinetics | SCHEDULE 13G/A: Others

Feb 7 10:25 ET

Crinetics | SCHEDULE 13G/A: Others

Feb 7 10:10 ET

Crinetics | 4: Statement of changes in beneficial ownership of securities-Officer Pizzuti Dana

Feb 5 16:35 ET

Crinetics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 3 08:49 ET

Crinetics | SCHEDULE 13G/A: Others

Jan 30 21:37 ET

Crinetics | 5: Annual statement of changes in beneficial ownership of securities-Officer Wilson Marc

Jan 29 16:31 ET

Crinetics | 5: Annual statement of changes in beneficial ownership of securities-Officer Betz Stephen F.

Jan 29 16:31 ET

Crinetics | 8-K: Current report

Jan 14 17:07 ET

Crinetics | 4: Statement of changes in beneficial ownership of securities-Officer Kalofonos Isabel

Jan 13 16:33 ET

Crinetics | 8-K: Current report

Jan 10 07:36 ET

Crinetics | 4: Statement of changes in beneficial ownership of securities-Officer Pizzuti Dana

Jan 7 16:34 ET